Pathophysiology
I-23. Overproduction of growth hormone and prolactin
成長ホルモン・プロラクチン過剰分泌
Growth Hormone Regulation & Effects
- GHRH (hypothalamus, pulsatile) → somatotrophs → GH; somatostatin inhibits GH.
- GH acts on nearly all organs (many effects via hepatic IGF-1):
- Liver: ↑protein synthesis, ↑gluconeogenesis, ↑IGF-1.
- Muscle: ↓glucose uptake, ↑AA uptake → ↑protein synthesis/muscle mass.
- Adipose: ↓glucose uptake, ↑lipolysis → ↓body fat.
- Most organs: ↑size/function; cartilage: ↑longitudinal bone growth.
Acromegaly / Gigantism
- Usually a pituitary GH adenoma (may compress optic fibers → visual field loss).
- Before epiphyseal closure → gigantism; after → acromegaly.
- Symptoms (4 groups):
- Diabetes mellitus: GH ↑blood glucose (↓muscle/adipose uptake, ↑hepatic gluconeogenesis) → insulin resistance → T2DM; glucosuria, polyuria, polydipsia, dyslipidemia.
- Bone/cartilage: continued bone growth → neuropathy, arthrosis, hand-foot-face deformities, large nose/jaw, separated teeth, carpal tunnel syndrome.
- Visceral growth: macroglossia, cardiomegaly (hypertension, arrhythmia), sweat/sebaceous gland hypertrophy, colon polyps.
- Prolactin-like effect: GH shares a precursor with prolactin → GH binds prolactin receptors and/or co-secretion → ↓GnRH → galactorrhea (women), gynecomastia (men).
Prolactin Regulation
- Inhibition: hypothalamic dopamine (main brake); prolactin induces dopamine → self-inhibition.
- Stimulation: TRH, estrogen, breast stimulation (inhibits dopamine).
- Effect: breast enlargement + milk production; inhibits GnRH (↓FSH/LH).
Hyperprolactinemia
Causes
- ↓Dopamine effect: breast stimulation; pituitary stalk injury/compression (↑prolactin, ↓other hormones).
- ↑TRH: primary/secondary hypothyroidism (no negative feedback → ↑TRH).
- Iatrogenic: dopamine-receptor-blocking drugs (antipsychotics, antihypertensives, anti-ulcer).
- Insufficient clearance: renal failure; macroprolactinemia (anti-prolactin antibodies → large prolactins, longer half-life; severe cases → functional hypo-prolactinemia).
- Prolactinoma (or prolactin + GH co-secreting adenoma).
Most common causes
- Physiological (pregnancy/breastfeeding), pituitary adenoma, iatrogenic.
Clinical presentation
- Most common pituitary disease.
- Early: galactorrhea (women), gynecomastia (men); ↓GnRH → hypogonadism (both sexes).
- Late: osteoporosis (from hypogonadism), inflammatory/autoimmune disease (prolactin’s cytokine-like effects), cognitive dysfunction.
- Treatment: dopamine agonist (BBB-crossing); surgery/irradiation/gamma knife for adenoma.
一問一答
▶What determines whether GH excess causes gigantism or acromegaly?
Timing relative to epiphyseal closure: before closure → gigantism; after closure → acromegaly.
▶What is the usual cause of acromegaly/gigantism?
A pituitary GH-producing adenoma, which may also compress optic fibers → visual field loss.
▶How is growth hormone secretion regulated?
GHRH (hypothalamus, pulsatile) stimulates somatotrophs to release GH; somatostatin inhibits GH release.
▶How does GH exert most of its growth effects?
Largely via hepatic IGF-1; GH itself acts on most organs while IGF-1 mediates growth-promoting actions.
▶What are GH's metabolic effects on liver, muscle, and adipose tissue?
Liver: ↑protein synthesis, ↑gluconeogenesis, ↑IGF-1. Muscle: ↓glucose uptake, ↑amino-acid uptake → ↑protein/muscle mass. Adipose: ↓glucose uptake, ↑lipolysis → ↓body fat.
▶Why does GH excess cause diabetes mellitus?
GH raises blood glucose (↓muscle/adipose uptake, ↑hepatic gluconeogenesis) → insulin resistance → type 2 DM with glucosuria, polyuria, polydipsia, and dyslipidemia.
▶What bone and cartilage features occur in acromegaly?
Continued bone/cartilage growth → hand-foot-face deformities, large nose/jaw, separated teeth, arthrosis, neuropathy, and carpal tunnel syndrome.
▶What visceral changes occur in acromegaly?
Macroglossia, cardiomegaly (with hypertension and arrhythmia), sweat/sebaceous gland hypertrophy, and colon polyps.
▶Why can GH excess cause galactorrhea/gynecomastia?
GH shares a precursor with prolactin, so it can bind prolactin receptors (and/or be co-secreted) → ↓GnRH → galactorrhea in women and gynecomastia in men.
▶How is prolactin secretion regulated?
Hypothalamic dopamine is the main inhibitor (and prolactin induces dopamine → self-inhibition); TRH, estrogen, and breast stimulation increase prolactin.
▶What are the physiological effects of prolactin?
Breast enlargement and milk production, plus inhibition of GnRH (↓FSH/LH).
▶How does a pituitary stalk lesion cause hyperprolactinemia?
It interrupts dopamine delivery from the hypothalamus, releasing prolactin from inhibition (↑prolactin) while other pituitary hormones fall.
▶Why does primary hypothyroidism cause hyperprolactinemia?
Loss of negative feedback raises TRH, which stimulates prolactin secretion.
▶Which drugs cause iatrogenic hyperprolactinemia?
Dopamine-receptor-blocking drugs — antipsychotics, some antihypertensives, and anti-ulcer agents.
▶What is macroprolactinemia?
Anti-prolactin antibodies bind prolactin into large complexes with a longer half-life; severe cases reduce biologically active prolactin (functional hypoprolactinemia).
▶What are the most common causes of hyperprolactinemia?
Physiological (pregnancy/breastfeeding), a pituitary adenoma (prolactinoma), and iatrogenic (drugs).
▶What are the early clinical features of hyperprolactinemia?
Galactorrhea (women), gynecomastia (men), and hypogonadism in both sexes from ↓GnRH.
▶What are the late consequences of chronic hyperprolactinemia?
Osteoporosis (from hypogonadism), inflammatory/autoimmune disease (prolactin's cytokine-like effects), and cognitive dysfunction.
▶What is the treatment of hyperprolactinemia/prolactinoma?
A BBB-crossing dopamine agonist; surgery, irradiation, or gamma knife for an adenoma.
▶Why can a pituitary adenoma cause visual field defects?
An expanding adenoma compresses the optic chiasm/fibers, producing visual field loss (classically bitemporal).